DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Singapore Medical Tourism Market and Forecast To 2022" report to their offering.
Singapore medical tourism market is likely to grow with single digit CAGR during the period 2017 - 2022
International patients come to Singapore each year for a whole range of medical care from health screenings to high-end surgical procedures in specialties such as cardiology, neurology, oncology, ophthalmology, organ transplants, orthopedics, and pediatrics. However, in recent years, Singapore is finding it harder to retain its title as the region's top medical tourism destination, as patient's eye better value for money in neighboring countries such as Thailand, Malaysia and India. The government support for medical tourism in Singapore has also waned in couple of years. It will be increasingly difficult for Singapore to maintain its position as the leading medical-tourism hub in South-east Asia, given the high cost of medical treatment and strength of the Singapore dollar.
Among the top source market for Singapore Medical Tourism, Indonesia topped the list as all other countries combined market share is lower than that of Indonesia alone. Malaysia is standing at the second spot in terms of medical tourist arrivals to Singapore in 2016. China is the third largest source market for Singapore medical tourism. United States, Philippines, Africa and India are competing closely to grab maximum share of the Singapore medical tourism market. Australia, UK, Hong Kong and Thailand are the other popular source market for Singapore medical tourism.
Key Topics Covered:
1. Executive Summary
2. Singapore Medical Tourist Arrivals and Forecast (2004 - 2022)
3. Singapore Medical Tourism Market and Forecast (2003 - 2022)
4. Singapore Medical Tourism - Country Wise Medical Tourist Arrivals, Spending and Forecast
For more information about this report visit https://www.researchandmarkets.com/research/c3twd2/singapore_medical